Ratings by H.C. Wainwright (Raghuram Selvaraju)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2024 | Microbot Medical | MBOT | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2024 | Oncternal Therapeutics | ONCT | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2024 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2024 | Fennec Pharmaceuticals Inc. | FENC | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2024 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2024 | Landos Biopharma | LABP | Downgrade | Neutral (Buy) |
21.48 (21.82) |
1.58% | Details | |
| 3/26/2024 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2024 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Synlogic Inc. | SYBX | Upgrade | Neutral (Sell) |
1.78 (1.87) |
5.06% | Details | |
| 3/18/2024 | Black Diamond Therapeutics | BDTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Co-Diagnostics | CODX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/14/2024 | Spruce Biosciences, Inc. | SPRB | Downgrade | Neutral (Buy) |
5.19 (0.70) |
-86.51% | Details | |
| 3/11/2024 | Brainsway | BWAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Rapt Therapeutics | RAPT | Downgrade | Neutral (Buy) |
6.87 (7.95) |
15.72% | Details | |
| 2/20/2024 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2024 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Synlogic Inc. | SYBX | Downgrade | Sell (Buy) |
3.45 (1.87) |
-45.8% | Details | |
| 1/29/2024 | Oncternal Therapeutics | ONCT | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2024 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2024 | Aclaris Therapeutis | ACRS | Downgrade | Neutral (Buy) |
1.14 (1.24) |
8.77% | Details | |
| 1/18/2024 | Taro Pharmaceutical Industries | TARO | Downgrade | Neutral (Buy) |
41.28 (42.25) |
2.35% | Details | |
| 1/9/2024 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2024 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2023 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Neutral (Buy) |
317.85 (329.83) |
3.77% | Details | |
| 12/11/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Æterna Zentaris | AEZS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Co-Diagnostics | CODX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2023 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Annovis Bio Inc. | ANVS | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | Protalix BioTherapeutics | PLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | Reviva Pharmaceuticals | RVPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2023 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2023 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.57 (0.90) |
-42.68% | Details | |
| 10/2/2023 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | Enlivex Therapeutics | ENLV | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | Kezer Life Sciences | KZR | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2023 | Oncternal Therapeutics | ONCT | Upgrade | Buy (Neutral) |
0.35 (8.86) |
2431.43% | Details | |
| 8/28/2023 | Arcadia Biosciences | RKDA | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2023 | Timber Pharmaceuticals | TMBR | Downgrade | Neutral (Buy) |
3.03 (0.34) |
-88.78% | Details | |
| 8/18/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2023 | Galera Therapeutics | GRTX | Downgrade | Neutral (Buy) |
0.27 (0.18) |
-33.33% | Details | |
| 8/15/2023 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | Co-Diagnostics | CODX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/14/2023 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Fennec Pharmaceuticals Inc. | FENC | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2023 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Black Diamond Therapeutics | BDTX | Upgrade | Buy (Neutral) |
6.18 (5.26) |
-14.89% | Details | |
| 6/5/2023 | Arcadia Biosciences | RKDA | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2023 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2023 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2023 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2023 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Microbot Medical | MBOT | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | Talaris Therapeutics | TALS | Downgrade | Neutral (Buy) |
1.94 (2.72) |
40.21% | Details | |
| 4/14/2023 | Arcadia Biosciences | RKDA | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2023 | Brainsway | BWAY | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2023 | Timber Pharmaceuticals | TMBR | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Oncternal Therapeutics | ONCT | Downgrade | Neutral (Buy) |
0.79 (8.86) |
1021.52% | Details | |
| 3/31/2023 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | Spruce Biosciences, Inc. | SPRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | ORIC Pharamceuticals | ORIC | Upgrade | Buy (Neutral) |
4.62 (9.19) |
98.92% | Details | |
| 3/22/2023 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Indaptus Therapeutics | INDP | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Co-Diagnostics | CODX | Downgrade | Neutral (Buy) |
2.48 (1.15) |
-53.63% | Details | |
| 3/15/2023 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Provention Bio Inc. | PRVB | Downgrade | Neutral (Buy) |
23.97 (24.98) |
4.21% | Details | |
| 3/13/2023 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2023 | Aptinyx | APTX | Downgrade | Neutral (Buy) |
0.19 (0.06) |
-68.42% | Details | |
| 3/7/2023 | TCR2 Therapeutics | TCRR | Downgrade | Neutral (Buy) |
1.62 (1.48) |
-8.64% | Details | |
| 3/2/2023 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2023 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2023 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2023 | Replimune Group | REPL | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 1/25/2023 | Taro Pharmaceutical Industries | TARO | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2023 | Cocrystal Pharma | COCP | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2023 | Oramed Pharma | ORMP | Downgrade | Neutral (Buy) |
2.25 (2.27) |
0.89% | Details | |
| 1/5/2023 | Oncorus Inc. | ONCR | Downgrade | Neutral (Buy) |
0.30 (0.12) |
-60% | Details | |
| 1/3/2023 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2023 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2022 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Brainsway | BWAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2022 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | Fennec Pharmaceuticals Inc. | FENC | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2022 | Talaris Therapeutics | TALS | New Coverage | Buy (N/A) |
2.42 (2.72) |
12.4% | Details | |
| 9/27/2022 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2022 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2022 | Annovis Bio Inc. | ANVS | New Coverage | Buy (N/A) |
10.54 (10.06) |
-4.55% | Details | |
| 9/6/2022 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2022 | Entera Bio | ENTX | New Coverage | Buy (N/A) |
1.40 (1.99) |
42.14% | Details | |
| 8/30/2022 | ObsEva | OBSV | Downgrade | Neutral (Buy) |
0.21 (0.10) |
-52.38% | Details | |
| 8/29/2022 | Timber Pharmaceuticals | TMBR | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2022 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Taro Pharmaceutical Industries | TARO | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Æterna Zentaris | AEZS | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2022 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2022 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
5.53 (42.19) |
662.93% | Details | |
| 7/18/2022 | Angion Biomedica | ANGN | Downgrade | Neutral (Buy) |
1.06 (1.00) |
-5.66% | Details | |
| 7/11/2022 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2022 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2022 | Addex Therapeutics | ADXN | Downgrade | Neutral (Buy) |
1.11 (20.05) |
1706.31% | Details | |
| 6/23/2022 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2022 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2022 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Oncternal Therapeutics | ONCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Angion Biomedica | ANGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Timber Pharmaceuticals | TMBR | New Coverage | Buy (N/A) |
0.39 (0.34) |
-12.82% | Details | |
| 3/29/2022 | Gain Therapeutics | GANX | New Coverage | Buy (N/A) |
3.96 (3.18) |
-19.7% | Details | |
| 3/28/2022 | ObsEva | OBSV | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2022 | ORIC Pharamceuticals | ORIC | Downgrade | Neutral (Buy) |
4.92 (9.19) |
86.79% | Details | |
| 3/24/2022 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2022 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2022 | Black Diamond Therapeutics | BDTX | Downgrade | Neutral (Buy) |
3.11 (5.26) |
69.13% | Details | |
| 3/16/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2022 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2022 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2022 | Addex Therapeutics | ADXN | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2022 | Indaptus Therapeutics | INDP | New Coverage | Buy (N/A) |
4.59 (2.36) |
-48.58% | Details | |
| 1/31/2022 | Genmab A/S | GMAB | Upgrade | Buy (Neutral) |
32.85 (28.70) |
-12.63% | Details | |
| 1/18/2022 | Taro Pharmaceutical Industries | TARO | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Brickell Biotech Inc. | BBI | New Coverage | Buy (N/A) |
0.21 (2.35) |
1019.05% | Details | |
| 1/10/2022 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2021 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Ayala Pharmaceuticals | AYLA | New Coverage | Buy (N/A) |
9.03 (0.50) |
-94.46% | Details | |
| 12/15/2021 | Galera Therapeutics | GRTX | Upgrade | Buy (Neutral) |
2.70 (0.18) |
-93.33% | Details | |
| 12/2/2021 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | Brainsway | BWAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | ObsEva | OBSV | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2021 | Inmed Pharmaceuticals | INM | New Coverage | Buy (N/A) |
1.68 (0.29) |
-82.74% | Details | |
| 11/22/2021 | Vallon Pharmaceuticals | VLON | New Coverage | Buy (N/A) |
4.44 (0.40) |
-90.99% | Details | |
| 11/16/2021 | Spruce Biosciences, Inc. | SPRB | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2021 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Angion Biomedica | ANGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2021 | Æterna Zentaris | AEZS | New Coverage | Buy (N/A) |
0.59 (1.95) |
230.51% | Details | |
| 10/20/2021 | Galera Therapeutics | GRTX | Downgrade | Neutral (Buy) |
2.25 (0.18) |
-92% | Details | |
| 10/13/2021 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2021 | Adamas Pharmaceuticals | ADMS | Downgrade | Neutral (Buy) |
8.07 (8.22) |
1.86% | Details | |
| 10/6/2021 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2021 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2021 | Itamar Medical | ITMR | Downgrade | Neutral (Buy) |
30.25 (30.87) |
2.05% | Details | |
| 9/7/2021 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 9/7/2021 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Genmab A/S | GMAB | Downgrade | Neutral (Buy) |
48.58 (28.70) |
-40.92% | Details | |
| 8/4/2021 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Spruce Biosciences, Inc. | SPRB | New Coverage | Buy (N/A) |
9.91 (0.70) |
-92.94% | Details | |
| 7/19/2021 | Brainsway | BWAY | New Coverage | Buy (N/A) |
9.00 (4.87) |
-45.89% | Details | |
| 7/12/2021 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2021 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2021 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2021 | Acorda Therapeutics, Inc. | ACOR | Upgrade | Buy (Neutral) |
4.10 (0.66) |
-83.9% | Details | |
| 6/16/2021 | Aclaris Therapeutis | ACRS | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Adamas Pharmaceuticals | ADMS | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2021 | Redhill Biopharma | RDHL | New Coverage | Buy (N/A) |
6.31 (0.45) |
-92.87% | Details | |
| 5/17/2021 | Exicure | XCUR | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Cardiff Oncology | CRDF | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Protalix BioTherapeutics | PLX | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2021 | Addex Therapeutics | ADXN | New Coverage | Buy (N/A) |
10.15 (20.05) |
97.54% | Details | |
| 4/21/2021 | Aclaris Therapeutis | ACRS | New Coverage | Buy (N/A) |
26.46 (1.24) |
-95.31% | Details | |
| 4/12/2021 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2021 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2021 | Eyenovia | EYEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2021 | ORIC Pharamceuticals | ORIC | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2021 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Enlivex Therapeutics | ENLV | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | Angion Biomedica | ANGN | New Coverage | Buy (N/A) |
17.34 (1.00) |
-94.23% | Details | |
| 2/22/2021 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2021 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2021 | TFF Parmaceuticals | TFFP | New Coverage | Buy (N/A) |
17.69 (3.11) |
-82.42% | Details | |
| 2/2/2021 | Adamas Pharmaceuticals | ADMS | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Viela Bio | VIE | Downgrade | Neutral (Buy) |
52.81 (53.01) |
0.38% | Details | |
| 1/20/2021 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2020 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/24/2020 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2020 | Galera Therapeutics | GRTX | New Coverage | Buy (N/A) |
10.92 (0.18) |
-98.35% | Details | |
| 11/30/2020 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2020 | Urovant Ltd. | UROV | Downgrade | Neutral (Buy) |
16.02 (16.24) |
1.37% | Details | |
| 10/22/2020 | Cardiff Oncology | CRDF | New Coverage | Buy (N/A) |
12.02 (4.35) |
-63.81% | Details | |
| 10/21/2020 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2020 | BioSpecifics Technologies | BSTC | Downgrade | Neutral (Buy) |
88.69 (88.53) |
-0.18% | Details | |
| 10/15/2020 | Replimune Group | REPL | Upgrade | Buy (Neutral) |
36.25 (6.45) |
-82.21% | Details | |
| 10/9/2020 | EyePoint Pharmaceuticals, Inc. | EYPT | Upgrade | Buy (Neutral) |
0.53 (17.65) |
3230.19% | Details | |
| 9/15/2020 | Spring Works Therapeutics | SWTX | Maintain | Buy (Buy) |
|
Details | ||
| 8/24/2020 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2020 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2020 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2020 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2020 | Microbot Medical | MBOT | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2020 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | Eyenovia | EYEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | Viela Bio | VIE | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Repro Med Systems | KRMD | New Coverage | Buy (N/A) |
8.86 (2.08) |
-76.52% | Details | |
| 8/10/2020 | Oncternal Therapeutics | ONCT | New Coverage | Buy (N/A) |
2.82 (8.86) |
214.18% | Details | |
| 8/6/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | ORIC Pharamceuticals | ORIC | New Coverage | Buy (N/A) |
20.07 (9.19) |
-54.21% | Details | |
| 7/28/2020 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | TCR2 Therapeutics | TCRR | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2020 | Arch Therapeutics | ARTH | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2020 | Equillium | EQ | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | Cocrystal Pharma Inc. | COCP | New Coverage | Buy (N/A) |
1.60 (1.53) |
-4.38% | Details | |
| 6/30/2020 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | BioNTech | BNTX | Downgrade | Neutral (Buy) |
65.80 (86.81) |
31.93% | Details | |
| 6/29/2020 | Inovio Pharmaceuticals | INO | Downgrade | Neutral (Buy) |
29.98 (9.68) |
-67.71% | Details | |
| 6/25/2020 | BioNTech | BNTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2020 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2020 | Evoke Pharma | EVOK | Upgrade | Buy (Neutral) |
2.35 (0.47) |
-80% | Details | |
| 6/17/2020 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2020 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Neurobo Pharmaceuticals | NRBO | New Coverage | Buy (N/A) |
9.73 (3.37) |
-65.36% | Details | |
| 6/12/2020 | Viela Bio | VIE | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2020 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2020 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Protalix BioTherapeutics | PLX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Protalix BioTherapeutics | PLX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Oragenics | OGEN | Downgrade | Neutral (Buy) |
0.56 (1.13) |
101.79% | Details | |
| 6/1/2020 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Rapt Therapeutics | RAPT | New Coverage | Buy (N/A) |
18.28 (7.95) |
-56.51% | Details | |
| 5/28/2020 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
87.97 (329.83) |
274.93% | Details | |
| 5/27/2020 | Kala Pharmaceuticals | KALA | Maintain | Buy (Buy) |
|
Details | ||
| 5/26/2020 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2020 | Revolution | RVMD | New Coverage | Buy (N/A) |
35.93 (34.92) |
-2.81% | Details | |
| 5/19/2020 | BioNTech | BNTX | Upgrade | Buy (Neutral) |
60.17 (86.81) |
44.27% | Details | |
| 5/18/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2020 | Viela Bio | VIE | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Stemline Therapeutics | STML | Downgrade | Neutral (Buy) |
12.11 (11.83) |
-2.31% | Details | |
| 5/4/2020 | Black Diamond Therapeutics | BDTX | New Coverage | Buy (N/A) |
34.49 (5.26) |
-84.75% | Details | |
| 4/29/2020 | Inovio Pharmaceuticals | INO | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2020 | Aptinyx | APTX | New Coverage | Buy (N/A) |
2.49 (0.06) |
-97.59% | Details | |
| 4/28/2020 | Selecta Biosciences | SELB | New Coverage | Buy (N/A) |
2.64 (0.88) |
-66.67% | Details | |
| 4/16/2020 | Oragenics | OGEN | Downgrade | Neutral (Buy) |
0.46 (0.56) |
21.74% | Details | |
| 4/15/2020 | Genmab A/S | GMAB | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2020 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2020 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
28.38 (24.74) |
-12.83% | Details | |
| 4/9/2020 | Zosano Pharma | ZSAN | New Coverage | Buy (N/A) |
0.53 (0.56) |
5.66% | Details | |
| 3/26/2020 | Eyenovia | EYEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2020 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2020 | Itamar Medical | ITMR | New Coverage | Buy (N/A) |
8.45 (30.87) |
265.33% | Details | |
| 3/19/2020 | Spring Works Therapeutics | SWTX | Upgrade | Buy (Neutral) |
21.96 (40.10) |
82.6% | Details | |
| 3/16/2020 | Anavex Life Sciences | AVXL | New Coverage | Buy (N/A) |
2.65 (3.78) |
42.64% | Details | |
| 3/11/2020 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2020 | Enlivex Therapeutics | ENLV | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2020 | BioNTech | BNTX | New Coverage | Neutral (N/A) |
38.09 (86.81) |
127.91% | Details | |
| 3/4/2020 | Spring Works Therapeutics | SWTX | Downgrade | Neutral (Buy) |
41.21 (21.96) |
-46.71% | Details | |
| 2/26/2020 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Co-Diagnostics | CODX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Balchem | BCPC | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Viela Bio | VIE | New Coverage | Buy (N/A) |
37.51 (53.01) |
41.32% | Details | |
| 2/14/2020 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2020 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Microbot Medical | MBOT | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | ChromaDex | CDXC | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Enlivex Therapeutics | ENLV | New Coverage | Buy (N/A) |
8.65 (1.32) |
-84.74% | Details | |
| 1/8/2020 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2019 | Sol Gel Technologies Ltd. | SLGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/31/2019 | Urovant Ltd. | UROV | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2019 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 12/24/2019 | Microbot Medical | MBOT | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | BioLife Solutions | BLFS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2019 | Spring Works Therapeutics | SWTX | New Coverage | Buy (N/A) |
25.91 (40.10) |
54.77% | Details | |
| 12/2/2019 | Cerecor | CERC | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Bausch Health Companies | BHC | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2019 | Neon Therapeutics | NTGN | Downgrade | Neutral (Buy) |
1.27 (3.07) |
141.73% | Details | |
| 11/11/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | Downgrade | Neutral (Buy) |
1.45 (17.65) |
1117.24% | Details | |
| 11/6/2019 | Exicure | XCUR | New Coverage | Buy (N/A) |
2.53 (0.56) |
-77.87% | Details | |
| 11/4/2019 | Y-mAbs Therapeutics | YMAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Eyenovia | EYEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2019 | Rockwell Medical Technologies | RMTI | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2019 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Foamix Pharmaceuticals | FOMX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2019 | Foamix Pharmaceuticals | FOMX | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2019 | NuCana | NCNA | New Coverage | Buy (N/A) |
6.95 (3.78) |
-45.61% | Details | |
| 8/14/2019 | Acorda Therapeutics, Inc. | ACOR | Downgrade | Neutral (Buy) |
2.73 (0.66) |
-75.82% | Details | |
| 8/12/2019 | Abeona Therapeutics | ABEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Balchem | BCPC | Maintain | (N/A) |
|
Details | ||
| 7/22/2019 | Microbot Medical | MBOT | New Coverage | Buy (N/A) |
5.13 (0.87) |
-83.04% | Details | |
| 7/22/2019 | Repligen | RGEN | Upgrade | Buy (Neutral) |
87.79 (157.14) |
79% | Details | |
| 7/22/2019 | BioLife Solutions | BLFS | New Coverage | Buy (N/A) |
16.97 (15.86) |
-6.54% | Details | |
| 7/16/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Neon Therapeutics | NTGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Aquestive Therapeutics | AQST | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Provention Bio Inc. | PRVB | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2019 | Acer Therapeutics | ACER | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2019 | Eton Pharmaceuticals | ETON | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2019 | Eton Pharmaceuticals | ETON | New Coverage | Buy (N/A) |
7.84 (3.19) |
-59.31% | Details | |
| 5/30/2019 | Neon Therapeutics | NTGN | New Coverage | Buy (N/A) |
5.41 (1.27) |
-76.52% | Details | |
| 5/13/2019 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
5.57 (1.45) |
-73.97% | Details | |
| 5/9/2019 | CareDx, Inc | CDNA | Upgrade | Buy (Neutral) |
29.15 (79.26) |
171.9% | Details | |
| 4/26/2019 | Oragenics | OGEN | New Coverage | Buy (N/A) |
0.49 (0.46) |
-6.12% | Details | |
| 4/1/2019 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
22.50 (15.13) |
-32.76% | Details | |
| 4/1/2019 | Cerecor | CERC | New Coverage | Buy (N/A) |
5.66 (2.93) |
-48.23% | Details | |
| 3/19/2019 | BioSpecifics Technologies | BSTC | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2019 | Protalix BioTherapeutics | PLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2019 | Kitov Pharmaceuticals | KTOV | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2019 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2019 | Arch Therapeutics | ARTH | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | NovaBay Pharmaceuticals | NBY | Downgrade | Neutral (Buy) |
1.39 (0.08) |
-94.24% | Details | |
| 3/11/2019 | Co-Diagnostics | CODX | New Coverage | Buy (N/A) |
1.23 (1.15) |
-6.5% | Details | |
| 3/11/2019 | Urovant Ltd. | UROV | New Coverage | Buy (N/A) |
13.15 (16.02) |
21.83% | Details | |
| 3/7/2019 | CareDx, Inc | CDNA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/5/2019 | Evoke Pharma | EVOK | Downgrade | Neutral (Buy) |
1.30 (0.47) |
-63.85% | Details | |
| 3/4/2019 | Omeros Corp. | OMER | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | DENTSPLY International | XRAY | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2019 | Evofem Biosciences Inc | EVFM | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Immunomedics | IMMU | New Coverage | Buy (N/A) |
15.76 (87.86) |
457.49% | Details | |
| 3/1/2019 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2019 | Motif Bio plc | MTFB | Downgrade | Neutral (Buy) |
1.92 (0.11) |
-94.27% | Details | |
| 2/25/2019 | Vical | VICL | Downgrade | Neutral (Buy) |
1.00 (0.68) |
-32% | Details | |
| 2/25/2019 | Ironwood Pharmaceuticals | IRWD | Upgrade | Neutral (Sell) |
14.18 (7.92) |
-44.15% | Details | |
| 2/7/2019 | ADMA Biologics | ADMA | New Coverage | Buy (N/A) |
2.89 (6.27) |
116.96% | Details | |
| 1/29/2019 | UroGen Pharma | URGN | New Coverage | Buy (N/A) |
42.50 (13.73) |
-67.69% | Details | |
| 1/18/2019 | Provention Bio Inc. | PRVB | New Coverage | Buy (N/A) |
2.34 (24.98) |
967.52% | Details | |
| 12/14/2018 | Bausch Health Companies | BHC | Upgrade | Buy (Neutral) |
24.13 (8.69) |
-63.99% | Details | |
| 12/12/2018 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2018 | Cellect Biotechnology | APOP | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Foamix Pharmaceuticals | FOMX | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2018 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
25.99 (17.24) |
-33.67% | Details | |
| 11/7/2018 | OncoSec Medical | ONCS | Downgrade | Neutral (Buy) |
0.87 (0.28) |
-67.82% | Details | |
| 10/9/2018 | Eyenovia | EYEN | New Coverage | Buy (N/A) |
3.90 (2.15) |
-44.87% | Details | |
| 10/4/2018 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2018 | Genmab | GMXAY | New Coverage | Buy (N/A) |
16.04 (18.35) |
14.4% | Details | |
| 10/1/2018 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2018 | Repligen | RGEN | New Coverage | Neutral (N/A) |
55.07 (87.79) |
59.42% | Details | |
| 9/25/2018 | Balchem | BCPC | New Coverage | Buy (N/A) |
116.06 (143.48) |
23.63% | Details | |
| 9/18/2018 | CareDx, Inc | CDNA | Maintain | Neutral (N/A) |
|
Details | ||
| 9/17/2018 | Acorda Therapeutics, Inc. | ACOR | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2018 | Sensus Healthcare | SRTS | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2018 | Foamix Pharmaceuticals | FOMX | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2018 | Bausch Health Companies | BHC | Maintain | Neutral (N/A) |
|
Details | ||
| 9/13/2018 | CytomX Therapeutics | CTMX | New Coverage | Buy (N/A) |
20.01 (1.67) |
-91.65% | Details | |
| 9/12/2018 | Foamix Pharmaceuticals | FOMX | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2018 | Caladrius Biosciences | CLBS | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2018 | Sensus Healthcare | SRTS | New Coverage | Buy (N/A) |
6.98 (3.29) |
-52.87% | Details | |
| 8/24/2018 | Kala Pharmaceuticals | KALA | Maintain | Buy (N/A) |
|
Details |
